Melinda M. Mortenson

1.4k total citations
22 papers, 992 citations indexed

About

Melinda M. Mortenson is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Melinda M. Mortenson has authored 22 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Melinda M. Mortenson's work include Pancreatic and Hepatic Oncology Research (7 papers), Cell death mechanisms and regulation (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Melinda M. Mortenson is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cell death mechanisms and regulation (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Melinda M. Mortenson collaborates with scholars based in United States and Grenada. Melinda M. Mortenson's co-authors include Richard J. Bold, Subbulakshmi Virudachalam, Michael G. Schlieman, Douglas B. Evans, Jean‐Nicolas Vauthey, Eddie K. Abdalla, Bridget N. Fahy, Jeffrey E. Lee, Scott Kopetz and Christopher R. Garrett and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Surgery and Journal of Cellular Biochemistry.

In The Last Decade

Melinda M. Mortenson

22 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melinda M. Mortenson United States 15 488 440 220 217 174 22 992
Masaki Mizumoto Japan 15 510 1.0× 348 0.8× 517 2.4× 395 1.8× 193 1.1× 24 1.5k
Masaru Inagaki Japan 15 302 0.6× 417 0.9× 312 1.4× 189 0.9× 155 0.9× 115 952
Hirofumi Hasegawa Japan 16 193 0.4× 419 1.0× 197 0.9× 550 2.5× 133 0.8× 49 1.0k
Felix Geißler Germany 18 490 1.0× 481 1.1× 337 1.5× 134 0.6× 94 0.5× 34 1.2k
Saiho Ko Japan 19 215 0.4× 561 1.3× 181 0.8× 472 2.2× 140 0.8× 68 1.3k
Zhe Su China 16 314 0.6× 150 0.3× 307 1.4× 86 0.4× 169 1.0× 42 857
Hikaru Fujioka Japan 20 211 0.4× 579 1.3× 121 0.6× 436 2.0× 184 1.1× 67 1.0k
Xiaoping Geng China 17 205 0.4× 246 0.6× 320 1.5× 159 0.7× 147 0.8× 81 886
Hideaki Kinugasa Japan 20 531 1.1× 255 0.6× 447 2.0× 126 0.6× 280 1.6× 64 1.2k

Countries citing papers authored by Melinda M. Mortenson

Since Specialization
Citations

This map shows the geographic impact of Melinda M. Mortenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda M. Mortenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda M. Mortenson more than expected).

Fields of papers citing papers by Melinda M. Mortenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda M. Mortenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda M. Mortenson. The network helps show where Melinda M. Mortenson may publish in the future.

Co-authorship network of co-authors of Melinda M. Mortenson

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda M. Mortenson. A scholar is included among the top collaborators of Melinda M. Mortenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda M. Mortenson. Melinda M. Mortenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakedis, Jeffery, Brooke Vuong, Liisa Lyon, et al.. (2021). Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective. Annals of Surgical Oncology. 28(10). 5648–5656. 7 indexed citations
2.
Liu, Bowei, Sharon Shiraga, Melinda M. Mortenson, & Jinping Lai. (2020). Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient With History of Laryngeal Squamous Cell Carcinoma. Anticancer Research. 40(12). 7053–7056. 1 indexed citations
3.
Brouquet, Antoine, Melinda M. Mortenson, Jean‐Nicolas Vauthey, et al.. (2010). Surgical Strategies for Synchronous Colorectal Liver Metastases in 156 Consecutive Patients: Classic, Combined or Reverse Strategy?. Journal of the American College of Surgeons. 210(6). 934–941. 175 indexed citations
4.
Katz, Matthew H. G., Melinda M. Mortenson, Huamin Wang, et al.. (2008). Diagnosis and Management of Cystic Neoplasms of the Pancreas: An Evidence-Based Approach. Journal of the American College of Surgeons. 207(1). 106–120. 35 indexed citations
5.
Mortenson, Melinda M., Yan Xing, Jeffrey E. Lee, et al.. (2008). Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311). World Journal of Surgical Oncology. 6(1). 63–63. 45 indexed citations
6.
Mortenson, Melinda M., Matthew H. G. Katz, Eric P. Tamm, et al.. (2008). Current diagnosis and management of unusual pancreatic tumors. The American Journal of Surgery. 196(1). 100–113. 58 indexed citations
7.
Mortenson, Melinda M., Douglas B. Evans, Jeffrey E. Lee, et al.. (2008). Parathyroid Exploration in the Reoperative Neck: Improved Preoperative Localization with 4D-Computed Tomography. Journal of the American College of Surgeons. 206(5). 888–895. 145 indexed citations
8.
Mortenson, Melinda M., Oren Gilad, Michael G. Schlieman, et al.. (2007). BCL‐2 functions as an activator of the AKT signaling pathway in pancreatic cancer. Journal of Cellular Biochemistry. 102(5). 1171–1179. 42 indexed citations
9.
Mortenson, Melinda M., Vijay P. Khatri, Joseph Bennett, & Nicholas J. Petrelli. (2007). Total Mesorectal Excision and Pelvic Node Dissection for Rectal Cancer: An Appraisal. Surgical Oncology Clinics of North America. 16(1). 177–197. 20 indexed citations
10.
Chun, Yun Shin, Dario Ribero, Eddie K. Abdalla, et al.. (2007). Comparison of Two Methods of Future Liver Remnant Volume Measurement. Journal of Gastrointestinal Surgery. 12(1). 123–128. 73 indexed citations
11.
Mortenson, Melinda M., Hung S. Ho, & Richard J. Bold. (2005). An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer. The American Journal of Surgery. 190(3). 406–411. 19 indexed citations
12.
Mortenson, Melinda M., Michael G. Schlieman, Subbulakshmi Virudachalam, et al.. (2005). Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer. Lung Cancer. 49(2). 163–170. 45 indexed citations
13.
Fahy, Bridget N., Michael G. Schlieman, Melinda M. Mortenson, Subbulakshmi Virudachalam, & Richard J. Bold. (2005). Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib. Cancer Chemotherapy and Pharmacology. 56(1). 46–54. 107 indexed citations
14.
Mortenson, Melinda M.. (2004). Immediate Breast Reconstruction After Mastectomy Increases Wound Complications. Archives of Surgery. 139(9). 988–988. 100 indexed citations
15.
Mortenson, Melinda M., et al.. (2004). Increasing BAK expression in pancreatic cancer: A novel method of chemosensitization. Journal of the American College of Surgeons. 199(3). 84–84. 1 indexed citations
16.
Mortenson, Melinda M., M.G. Schlieman, S. Virudachalam, et al.. (2004). Effects of the 26S proteasome inhibitor, bortezomib, on BCL-2 in small cell lung cancer: Implications for SWOG-0327. Journal of Clinical Oncology. 22(14_suppl). 9560–9560. 2 indexed citations
17.
Galante, Joseph M., Melinda M. Mortenson, M.G. Schlieman, S. Virudachalam, & Richard J. Bold. (2004). Targeting NF-kB/BCL-2 pathway increases apoptotic susceptibility to chemotherapy in pancreatic cancer. Journal of Surgical Research. 121(2). 306–307. 11 indexed citations
18.
Lara, Primo N., Angela M. Davies, Philip C. Mack, et al.. (2004). Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy. Seminars in Oncology. 31(1 Suppl 1). 40–46. 31 indexed citations
19.
Mortenson, Melinda M., et al.. (2003). Overexpression of BCL-2 results in activation of the AKT/NF-kB Cell survival pathway. Journal of Surgical Research. 114(2). 302–302. 14 indexed citations
20.
Mortenson, Melinda M. & Richard J. Bold. (2002). Symptomatic Pancreatic Polypeptide-Secreting Tumor of the Distal Pancreas (PPoma). International Journal of Gastrointestinal Cancer. 32(2-3). 153–156. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026